Aarti Drugs posts Q3 FY24 consolidated PAT at Rs. 36.71 Cr
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Lack of technology transfer stands out as a formidable barrier
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The medical device sector is considered as one of the sunrise sectors in the country
Subscribe To Our Newsletter & Stay Updated